An overview of osimertinib as a treatment of non-small cell lung cancer (NSCLC): an update-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

An overview of osimertinib as a treatment of non-small cell lung cancer (NSCLC): an update

Published:2021-02-24 Issue:7 Volume:22 Page:809-819
ISSN:1465-6566
Container-title:Expert Opinion on Pharmacotherapy
language:en
Short-container-title:Expert Opinion on Pharmacotherapy

Author:

Cerbone Luigi¹²³,Benitez Jose Carlos¹,Planchard David¹⁴,Genova Carlo²³^ORCID

Affiliation:

1. Department of Medical Oncology, Thoracic Group, Gustave Roussy, Villejuif, France

2. Clinica Di Oncologia Medica, IRCCSO spedale Policlinico San Martino, Genova, Italy

3. Dipartimento Di Medicina Interna E Specialità Mediche, Università Degli Studi Di Genova, Genova, Italy

4. Paris-Saclay University, Cancer Campus Gustave Roussy, Gustave Roussy, Villejuifnnfg, France

Funder

not funded

Publisher

Informa UK Limited

Subject

Pharmacology (medical),Pharmacology,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/14656566.2021.1888928

Reference75 articles.

1. Activating Mutations in the Epidermal Growth Factor Receptor Underlying Responsiveness of Non–Small-Cell Lung Cancer to Gefitinib

2. AZD9291, an Irreversible EGFR TKI, Overcomes T790M-Mediated Resistance to EGFR Inhibitors in Lung Cancer

3. Osimertinib or Platinum–Pemetrexed in EGFR T790M–Positive Lung Cancer

4. The Effect of Food or Omeprazole on the Pharmacokinetics of Osimertinib in Patients With Non-Small-Cell Lung Cancer and in Healthy Volunteers

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Photonanozyme–Kras–ribosome combination treatment of non-small cell lung cancer after COVID-19;Frontiers in Immunology;2024-09-06

2. Role of circulating-tumor DNA in the early-stage non-small cell lung carcinoma as a predictive biomarker;Pathology - Research and Practice;2023-05

3. Clinical Utility and Outcomes Impact of Crystal Digital PCR of Sensitizing and Resistance EGFR Mutations in Patients With Advanced Non-Small Cell Lung Cancer;Clinical Lung Cancer;2022-09

4. Radiotherapy with continued EGFR‐TKIs for oligoprogressive disease in EGFR‐mutated non‐small cell lung cancer: A real‐world study;Cancer Medicine;2022-06-05

5. Synthesis, Biological Activity, and Molecular Modelling Studies of Naphthoquinone Derivatives as Promising Anticancer Candidates Targeting COX-2;Pharmaceuticals;2022-04-27

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3